PGHHNSEProcter & Gamble Hygiene and Health Care Limited· Personal ProductsHighNeutral
Announced Wed, 30 Jul, 2025 · 17:42 IST

Procter & Gamble Hygiene and Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

PGHH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹13870.00
prior close
₹13820.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-0.2% vs market
Personal Care peers, median of 12sector+0.7%-1.6% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 1.6 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.5
15m
-0.3
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9-0.7-0.2+0.7-1.6
Next day
-1.2-2.3+1.1+0.7-1.9
2d
-1.8-1.8-0.1+0.2-2.0
3d
-3.7-2.1-1.5+0.4-4.1
4d
-4.8-3.2-1.7-1.1-3.7
5d
-5.1-3.5-1.7-0.7-4.5
1w
-4.1-4.1-0.0-1.1-3.0
15d
-4.1-2.0-2.1-0.5-3.6
1m
-4.5-3.4-1.1+1.5-5.9
2m
+1.9-5.1+6.9-4.1+6.0
3m
-3.8-1.3-2.4-2.7-1.1
UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Procter & Gamble Hygiene and Health Care Limited has submitted its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) to BSE and NSE. The Board of Directors approved these results at a meeting held on July 30, 2025, which ran from 12:44 p.m. to 1:15 p.m. The filing includes the unaudited financial results along with a limited review report from the company's statutory auditors. This is a routine quarterly compliance filing required of all listed companies and does not itself contain the actual financial numbers, which are typically attached as a separate format-compliant document.

Likely market impact

This is a standard regulatory disclosure with no direct price impact on its own; investors should review the attached financial results for actual revenue, profit, and margin figures that will drive any stock reaction.